Srini Akkaraju, M.D., Ph.D.

Dr. Srinivas Akkaraju has served as a member of our board of directors since July 2022. Dr. Akkaraju is the Founder and Managing General Partner at Samsara BioCapital. Previously, from 2013 to 2016, he served as a General Partner of Sofinnova Ventures. Prior to that, he served as Managing Director of New Leaf Venture Partners. Earlier, he served as a Managing Director and Co-Founder at Panorama Capital, LLC, a private equity firm. Dr. Akkaraju was with J.P. Morgan Partners, which he joined in 2001 and of which he became a Partner in 2005. From October 1998 to April 2001, he was in Business and Corporate Development at Genentech, Inc. (now a wholly owned member of The Roche Group. Dr. Akkaraju is a member of the Board of Directors for Alumis, Inc., Mineralys Therapeutics Inc., vTv Therapeutics, Inc., Inventiva S.A., and Ottimo Pharma. Dr. Akkaraju previously served as director of Syros Pharmaceuticals, Inc., Chinook Therapeutics, Inc., Intercept Pharmaceuticals, Inc., Jiya Acquisition Corp., Seattle Genetics, Inc., and Principia Biopharma, Inc. Dr. Akkaraju received a M.D. and Ph.D. in Immunology from Stanford University. He received his undergraduate degrees in Biochemistry and Computer Science from Rice University.